HF/Transplantation News

Danon disease is a rare but serious cardiomyopathy that drastically reduces life expectancy.

AI-assisted diagnosis of asymptomatic left ventricular dysfunction may detect disease early and thereby expedite treatment of low ejection fraction, according to data published in JACC: Advances.

Researchers at St. Jude Children’s Research Hospital identified a panel of 27 serum proteins that accurately predicted cardiomyopathy risk among childhood cancer survivors treated with anthracycline chemotherapy.

Left ventricular assist devices, which are mechanical heart pumps, are an important treatment for patients with advanced heart failure.

In this Healio video exclusive, Jonathan H. Kim, MD, provides an overview of the recently published scientific statement on clinical considerations for participation of athletes with heart disease in competitive sports.

The American Board of Medical Specialties denied approval of creation of an independent cardiology certification board championed by the American Board of Cardiovascular Medicine, according to a press release.

Infections requiring hospitalization were associated with increased risk for future incident heart failure, regardless of infection and HF subtype, according to new data published in the Journal of the American Heart Association.

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance on competitive sports participation for athletes with cardiovascular disease.

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, according to data from a cohort study published in the Journal of Diabetes and Its Complications.